Cancers (Feb 2023)
Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. <i>Cancers</i> 2022, <i>14</i>, 1510
- Selinde S. Wind,
- Manon A. A. Jansen,
- Melanie Rijsbergen,
- Michiel J. van Esdonk,
- Dimitrios Ziagkos,
- Wing C. Cheng,
- Tessa Niemeyer-van der Kolk,
- John Korsten,
- Agnieszka Gruszka,
- Debora Schmitz-Rohmer,
- David Bonnel,
- Raphael Legouffe,
- Florian Barré,
- Marcel W. Bekkenk,
- Ellen R. M. de Haas,
- Koen D. Quint,
- Harald Schnidar,
- Melanie Rolli,
- Henk Johan Streefkerk,
- Jacobus Burggraaf,
- Maarten H. Vermeer,
- Robert Rissmann
Affiliations
- Selinde S. Wind
- Centre for Human Drug Research, 2333 CL Leiden, The Netherlands
- Manon A. A. Jansen
- Centre for Human Drug Research, 2333 CL Leiden, The Netherlands
- Melanie Rijsbergen
- Centre for Human Drug Research, 2333 CL Leiden, The Netherlands
- Michiel J. van Esdonk
- Centre for Human Drug Research, 2333 CL Leiden, The Netherlands
- Dimitrios Ziagkos
- Centre for Human Drug Research, 2333 CL Leiden, The Netherlands
- Wing C. Cheng
- Centre for Human Drug Research, 2333 CL Leiden, The Netherlands
- Tessa Niemeyer-van der Kolk
- Centre for Human Drug Research, 2333 CL Leiden, The Netherlands
- John Korsten
- Charles River Laboratories Den Bosch B.V., 5231 DD Den Bosch, The Netherlands
- Agnieszka Gruszka
- Charles River Laboratories Den Bosch B.V., 5231 DD Den Bosch, The Netherlands
- Debora Schmitz-Rohmer
- PIQUR Therapeutics AG, 4057 Basel, Switzerland
- David Bonnel
- MS Imaging Department, ImaBiotech, 59120 Lille, France
- Raphael Legouffe
- MS Imaging Department, ImaBiotech, 59120 Lille, France
- Florian Barré
- MS Imaging Department, ImaBiotech, 59120 Lille, France
- Marcel W. Bekkenk
- Amsterdam University Medical Centers, 1105 AZ Amsterdam, The Netherlands
- Ellen R. M. de Haas
- Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands
- Koen D. Quint
- Department of Dermatology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
- Harald Schnidar
- SCARLETRED Holding GmbH, 1030 Vienna, Austria
- Melanie Rolli
- PIQUR Therapeutics AG, 4057 Basel, Switzerland
- Henk Johan Streefkerk
- PIQUR Therapeutics AG, 4057 Basel, Switzerland
- Jacobus Burggraaf
- Centre for Human Drug Research, 2333 CL Leiden, The Netherlands
- Maarten H. Vermeer
- Department of Dermatology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
- Robert Rissmann
- Centre for Human Drug Research, 2333 CL Leiden, The Netherlands
- DOI
- https://doi.org/10.3390/cancers15051485
- Journal volume & issue
-
Vol. 15,
no. 5
p. 1485
Abstract
The authors wish to make the following corrections to this paper [...]
Keywords
